Key Drivers
- High gross margin
- Negative operating cash
- Elevated leverage
AIAI Summary
Telix has evolved into a revenue‑driven commercial imaging platform—so the investment thesis now hinges on execution (Illuccix/Gozellix adoption, reimbursement wins, and manufacturing scale) rather than pure clinical binary upside; investors should therefore prioritize quarterly cash‑flow inflection, FY26 revenue cadence vs. guide, and demonstrable net‑debt reduction as the key validation signals. The biggest immediate downside is balance‑sheet and legal fragility: continued negative operating cash flow, manufacturing or reimbursement setbacks, or an adverse securities outcome could force dilutive financing and materially compress the multiple.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Negative operating cash
- •Elevated leverage
TLX shows resilient product economics with high gross margins and modest operating profit but is a cash‑burning, highly leveraged company with a slight net loss and stretched valuation.
Price Behavior
Key Price Behavior Insights:
- •Short-term uptrend
- •Price stretched
- •Support cluster
TLX is in a short-term uptrend, trading at $8.75 (~15% above its last-month SMA of ~$7.58) and near a recent high, but the move is extended and vulnerable to a pullback with support near $7.60, $6.87 and $6.56.
Price ~15% above last-month
Sentiment & News
Key News Insights:
- •Commercial momentum
- •Phase 3 safety
- •Manufacturing expansion
Telix posted strong FY2025 results ($804M, +56%) led by Illuccix/Gozellix ($622M), signaled a path to a ~$1B run‑rate, advanced TLX591‑Tx Phase 3 safety objectives, resubmitted the TLX101‑Px NDA, and is scaling U.S. manufacturing while launching AI‑PET research.
The combination of robust commercial uptake, late‑stage therapeutic de‑risking, and manufacturing scale‑up materially improves Telix's near‑term revenue visibility and commercialization risk profile
Similar Companies in Healthcare
Other companies in the same sector with AI ratings